weight-loss pill

Washington, United States, January 25: Orlistat, the first over-the-counter weight-loss drug approved by FDA for sale in the United States, will now be available on the shelves of pharmacies across the United Kingdom in the next few months, the UK-based pharmaceutical company GlaxoSmithKline (GSK) said.

The pharmaceutical giant has received a non-prescription license from European regulators for its anti-obesity drug Orlistat (alli), meaning the British drugmaker can now introduce its first weight-loss drug for adults with a body mass indexdefine (BMI) of 28kg per metre squared or above, in all 27 EU member countries.